← Leaderboards
Jan-Peter Van Pijkeren
University Of Wisconsin-Madison
$5,046,267
Attributed
$5,046,267
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,046,267 · 6
By mechanism
R01$3,846,303 · 3
R21$1,199,964 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- S A Rankin$71
- Jason A Delborne$2,047,664
- Dominique Brossard$358,326
- Yoshihiro Kawaoka$200,000
- Michael A Xenos$342,013
Others in their field
Top investigators on “Probiotics”
- Gary Fanger · Rise Therapeutics, Llc$26,547,866
- Sarkis K Mazmanian · California Institute Of Technology$10,460,394
- Sabita Roy · University Of Minnesota Twin Cities$9,108,304
- Joel Palefsky · University Of California San Francisco$8,712,471
- Phillip I Tarr · Seattle Children'S Hospital$8,647,804
- Tal Danino · Columbia Univ New York Morningside$8,217,641
Research focus
ProbioticsEngineeringBacteriaBacteriophagesRecombinantsMediatingBaseMicrobeMicrobialPublishingCellsLactobacillus ReuteriCytolysisProductionIn VivoGastrointestinal Tract StructureComplexGrowthMicrobial CommunityMicrobiotaInnovationAnimal ModelClustered Regularly Interspaced Short Palindromic RepeatsSymbiont
Grant awards (16)
Prophage-mediated regulation of antimicrobial production$479,730
R01 · FY2025 · AI · contact PI
Dietary sugar-regulated recombinant protein production in the gut$427,625
R21 · FY2025 · AI · contact PI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri$376,518
R01 · FY2025 · AT · contact PI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri$409,987
R01 · FY2024 · AT · contact PI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri$418,354
R01 · FY2023 · AT · contact PI
Multi-tiered containment system for engineered microbes$305,672
R01 · FY2023 · GM · contact PI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri$413,378
R01 · FY2022 · AT · contact PI
Multi-tiered containment system for engineered microbes$305,672
R01 · FY2022 · GM · contact PI
Mechanism and application of sugar-induced phage production by the probiotic gut symbiont Lactobacillus reuteri$407,807
R01 · FY2021 · AT · contact PI
Multi-tiered containment system for engineered microbes$305,275
R01 · FY2021 · GM · contact PI
Acquisition of a parallel stirred-tank bioreactor system to accelerate and advance the development of next-generation probiotics$119,190
R01 · FY2021 · GM · contact PI
Multi-tiered containment system for engineered microbes$304,720
R01 · FY2020 · GM · contact PI
Development of a biological containment strategy for recombinant Lactobacillus reuteri$193,750
R21 · FY2020 · AI · contact PI
Development of a biological containment strategy for recombinant Lactobacillus reuteri$232,375
R21 · FY2019 · AI · contact PI
A biotherapeutic CRISPR-delivery platform to eradicate Clostridium difficile$166,482
R21 · FY2017 · AI · contact PI
A biotherapeutic CRISPR-delivery platform to eradicate Clostridium difficile$179,732
R21 · FY2016 · AI · contact PI